Topics
Diffuse midline glioma | Treatment | Immunotherapy | Overview
Home > Publications > Topics > Diffuse midline glioma > Treatment > Immunotherapy > Overview
Lin C, Smith C, Rutka J.
Current
immunotherapeutic approaches to diffuse intrinsic pontine glioma.
Front Genet. 2024 May 7;15:1349612. doi:
10.3389/fgene.2024.1349612. PMID:
38774284. Review. ˍ
Liu J, Ha JH, Abikenari M, Sjoholm MA, Annagiri S, Ravi K,
Bergsneider BH, Verma R, Theodros D, Medikonda R, Li G, Prolo LM,
Monje M, Lim M.
Adaptive
immunotherapeutic paradigms in diffuse midline glioma: integrating
epigenetic reprogramming, neuron-glioma interactions, and tumor
microenvironment modulation.
J
Neurooncol. 2025 Dec 29;176(2):144. doi:
10.1007/s11060-025-05347-9. PMID:
41460355. Review. ˍ
Ramsoomair CK, Sarmiento F, Ramsoomair D, Daftari M, He J, Glazer
B, Monje M, Reinberg D, Shah AH.
Deciphering
the tumor microenvironment and role of immunotherapy in Diffuse
Midline Glioma: a scoping review.
Neuro
Oncol. 2026 Feb 2:noag014. doi:
10.1093/neuonc/noag014. PMID:
41629217. Review. ˍ